Bagnasco, D.; Pini, L.; Bondi, B.; Montagnino, C.; Testino, E.; Capuano, V.; Pugliaro, C.; Brussino, L.; Nicola, S.; Caminati, M.;
et al. Carbon Footprint Impact, of Monoclonal Antibodies for Severe Asthma, Administered in Italy. Biomedicines 2025, 13, 1574.
https://doi.org/10.3390/biomedicines13071574
AMA Style
Bagnasco D, Pini L, Bondi B, Montagnino C, Testino E, Capuano V, Pugliaro C, Brussino L, Nicola S, Caminati M,
et al. Carbon Footprint Impact, of Monoclonal Antibodies for Severe Asthma, Administered in Italy. Biomedicines. 2025; 13(7):1574.
https://doi.org/10.3390/biomedicines13071574
Chicago/Turabian Style
Bagnasco, Diego, Laura Pini, Benedetta Bondi, Carola Montagnino, Elisa Testino, Veronica Capuano, Celeste Pugliaro, Luisa Brussino, Stefania Nicola, Marco Caminati,
and et al. 2025. "Carbon Footprint Impact, of Monoclonal Antibodies for Severe Asthma, Administered in Italy" Biomedicines 13, no. 7: 1574.
https://doi.org/10.3390/biomedicines13071574
APA Style
Bagnasco, D., Pini, L., Bondi, B., Montagnino, C., Testino, E., Capuano, V., Pugliaro, C., Brussino, L., Nicola, S., Caminati, M., Baiardini, I., & Braido, F.
(2025). Carbon Footprint Impact, of Monoclonal Antibodies for Severe Asthma, Administered in Italy. Biomedicines, 13(7), 1574.
https://doi.org/10.3390/biomedicines13071574
